|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 40.36 USD | +1.34% |
|
-4.19% | +42.32% |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 15.3B | 20.3B | 23.02B | 22.94B | 22.18B | |||||
Total Revenues | 15.3B | 20.3B | 23.02B | 22.94B | 22.18B | |||||
Cost of Goods Sold, Total | 13.28B | 17.05B | 18.66B | 18.64B | 18.7B | |||||
Gross Profit | 2.02B | 3.24B | 4.36B | 4.3B | 3.48B | |||||
Selling General & Admin Expenses, Total | 204M | 240M | 226M | 239M | 239M | |||||
Other Operating Expenses | 71M | - | 51M | 136M | 260M | |||||
Other Operating Expenses, Total | 275M | 240M | 277M | 375M | 499M | |||||
Operating Income | 1.74B | 3B | 4.08B | 3.93B | 2.98B | |||||
Interest Expense, Total | -529M | -492M | -476M | -450M | -440M | |||||
Interest And Investment Income | 60M | 117M | 81M | 97M | 88M | |||||
Net Interest Expenses | -469M | -375M | -395M | -353M | -352M | |||||
Income (Loss) On Equity Invest. | - | - | - | - | -50M | |||||
Currency Exchange Gains (Loss) | - | - | -131M | -34M | - | |||||
Other Non Operating Income (Expenses) | -79M | -180M | -84M | -155M | -105M | |||||
EBT, Excl. Unusual Items | 1.19B | 2.45B | 3.47B | 3.38B | 2.48B | |||||
Restructuring Charges | - | - | - | -63M | -352M | |||||
Merger & Related Restructuring Charges | - | - | - | - | - | |||||
Gain (Loss) On Sale Of Investments | - | - | - | 5M | -17M | |||||
Gain (Loss) On Sale Of Assets | 74M | - | - | - | - | |||||
Asset Writedown | - | -100M | - | -49M | -339M | |||||
Other Unusual Items | -15M | -238M | -110M | -43M | 1M | |||||
EBT, Incl. Unusual Items | 1.25B | 2.11B | 3.36B | 3.23B | 1.77B | |||||
Income Tax Expense | -216M | 515M | 701M | 718M | 479M | |||||
Earnings From Continuing Operations | 1.47B | 1.6B | 2.66B | 2.52B | 1.29B | |||||
Earnings Of Discontinued Operations | - | - | - | - | - | |||||
Net Income to Company | 1.47B | 1.6B | 2.66B | 2.52B | 1.29B | |||||
Minority Interest | -11M | -23M | -24M | -15M | -9M | |||||
Net Income - (IS) | 1.46B | 1.57B | 2.64B | 2.5B | 1.28B | |||||
Net Income to Common Incl Extra Items | 1.46B | 1.57B | 2.64B | 2.5B | 1.28B | |||||
Net Income to Common Excl. Extra Items | 1.46B | 1.57B | 2.64B | 2.5B | 1.28B | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 1.63 | 1.74 | 2.93 | 2.84 | 1.5 | |||||
Basic EPS - Continuing Operations | 1.63 | 1.74 | 2.93 | 2.84 | 1.5 | |||||
Basic Weighted Average Shares Outstanding | 892M | 904M | 899M | 882M | 853M | |||||
Net EPS - Diluted | 1.63 | 1.73 | 2.92 | 2.83 | 1.5 | |||||
Diluted EPS - Continuing Operations | 1.63 | 1.73 | 2.92 | 2.83 | 1.5 | |||||
Diluted Weighted Average Shares Outstanding | 892M | 908M | 902M | 883M | 853M | |||||
Normalized Basic EPS | 0.82 | 1.67 | 2.39 | 2.38 | 1.81 | |||||
Normalized Diluted EPS | 0.82 | 1.66 | 2.38 | 2.38 | 1.81 | |||||
Dividend Per Share | 0.18 | 0.48 | 0.64 | 0.68 | 0.68 | |||||
Payout Ratio | 11.05 | 27.67 | 21.83 | 23.99 | 45.13 | |||||
American Depositary Receipts Ratio (ADR) | 1 | 1 | 1 | 1 | 1 | |||||
Supplemental Items | ||||||||||
EBITDA | 2.64B | 3.94B | 5.08B | 5B | 4.12B | |||||
EBITA | 1.74B | 3B | 4.08B | 3.93B | 2.98B | |||||
EBIT | 1.74B | 3B | 4.08B | 3.93B | 2.98B | |||||
EBITDAR | 2.94B | 4.27B | 5.45B | 5.4B | 4.52B | |||||
Total Revenues (As Reported) | 15.3B | 20.3B | 23.02B | 22.94B | 22.18B | |||||
Effective Tax Rate - (Ratio) | -17.25 | 24.41 | 20.84 | 22.2 | 27.05 | |||||
Current Domestic Taxes | 0 | 28M | 33M | -1M | 8M | |||||
Current Foreign Taxes | 270M | 417M | 472M | 571M | 448M | |||||
Total Current Taxes | 270M | 445M | 505M | 570M | 456M | |||||
Deferred Domestic Taxes | -533M | 173M | 137M | 179M | 33M | |||||
Deferred Foreign Taxes | 47M | -103M | 59M | -31M | -10M | |||||
Total Deferred Taxes | -486M | 70M | 196M | 148M | 23M | |||||
Normalized Net Income | 735M | 1.51B | 2.15B | 2.1B | 1.54B | |||||
Interest on Long-Term Debt | 38M | 38M | 41M | 38M | 31M | |||||
Non-Cash Pension Expense | 25M | 14M | 32M | 43M | 57M | |||||
Supplemental Operating Expense Items | ||||||||||
General and Administrative Expenses | 204M | 240M | 226M | 239M | 239M | |||||
Research And Development Expense From Footnotes | 321M | 345M | 408M | 426M | 411M | |||||
Net Rental Expense, Total | 297M | 329M | 370M | 392M | 398M | |||||
Imputed Operating Lease Interest Expense | 118M | 133M | 156M | 159M | 164M | |||||
Imputed Operating Lease Depreciation | 179M | 196M | 214M | 233M | 234M | |||||
Stock-Based Comp., Other (Total) | 214M | 219M | 219M | 223M | 213M | |||||
Total Stock-Based Compensation | 214M | 219M | 219M | 223M | 213M |
- Stock Market
- Equities
- HAL Stock
- Financials Halliburton Company
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















